Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia

被引：47
作者：
Ulhaq, Zulvikar Syambani [1 ]
Soraya, Gita Vita [2 ]
机构：
[1] Maulana Malik Ibrahim Islamic State Univ Malang, Dept Biochem, Fac Med & Hlth Sci, Batu 65151, East Java, Indonesia
[2] Hasanuddin Univ, Dept Biochem, Fac Med, Makassar 90245, South Sulawesi, Indonesia
来源：
MEDICINA CLINICA | 2020年 / 155卷 / 12期
关键词：
OFF-LABEL USE; TOCILIZUMAB; INTERLEUKIN-6;
D O I：
10.1016/j.medcli.2020.07.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：548 / 556
页数：9
相关论文
共 50 条
  • [1] The role of IL-6 and IL-6 blockade in COVID-19
    Potere, Nicola
    Batticciotto, Alberto
    Vecchie, Alessandra
    Porreca, Ettore
    Cappelli, Antonella
    Abbate, Antonio
    Dentali, Francesco
    Bonaventura, Aldo
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (06) : 601 - 617
  • [2] The role of IL-6 in coronavirus, especially in COVID-19
    Wang, Xinyi
    Tang, Guozheng
    Liu, Yuchen
    Zhang, Lizhi
    Chen, Bangjie
    Han, Yanxun
    Fu, Ziyue
    Wang, Liuning
    Hu, Guangzhi
    Ma, Qing
    Sheng, Shuyan
    Wang, Jianpeng
    Hu, Xinyang
    Shao, Song
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [3] Outlook of IL-6 signaling blockade for COVID-19 pneumonia
    Misato Hashizume
    Inflammation and Regeneration, 40
  • [4] Anti-IL-6 receptor antibody does not ameliorate radiation pneumonia in mice
    Ogata, Toshiyuki
    Yamazaki, Hideya
    Teshima, Teruki
    Tsuchiya, Takahiro
    Nishimoto, Norihiro
    Matsuura, Nariaki
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2012, 4 (02) : 273 - 276
  • [5] Effects of anti-IL-6 receptor antibody on human monocytes
    Tono, Toshihiro
    Aihara, Satoko
    Hoshiyama, Takayuki
    Arinuma, Yoshiyuki
    Nagai, Tatsuo
    Hirohata, Shunsei
    MODERN RHEUMATOLOGY, 2015, 25 (01) : 79 - 84
  • [6] Anti-IL-6 receptor monoclonal antibody as a new treatment of endometriosis
    El-Zayadi, Ahmed A.
    Mohamed, Sara A.
    Arafa, Mohammad
    Mohammed, Shereen M.
    Zayed, Abdelhady
    Abdelhafez, Mohamed S.
    Badawy, Ahmed M.
    IMMUNOLOGIC RESEARCH, 2020, 68 (06) : 389 - 397
  • [7] Outlook of IL-6 signaling blockade for COVID-19 pneumonia
    Hashizume, Misato
    INFLAMMATION AND REGENERATION, 2020, 40 (01)
  • [8] Editorial: Tocilizumab, a Humanized Therapeutic IL-6 Receptor (IL-6R) Monoclonal Antibody, and Future Combination Therapies for Severe COVID-19
    Parums, Dinah V.
    MEDICAL SCIENCE MONITOR, 2021, 27
  • [9] Anti-IL-6 receptor antibody (tocilizumab): a B cell targeting therapy
    Snir, A.
    Kessel, A.
    Haj, T.
    Rosner, I.
    Slobodin, G.
    Toubi, E.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (04) : 697 - 700
  • [10] The differential response to anti IL-6 treatment in COVID-19: the genetic counterpart
    Perricone, C.
    Conigliaro, P.
    Ciccacci, C.
    Marcucci, E.
    Cafaro, G.
    Bartoloni, E.
    Perricone, R.
    Novelli, G.
    Borgiani, P.
    Gerli, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (03) : 580 - 580
12345